InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: None

Sunday, 01/21/2018 3:26:56 PM

Sunday, January 21, 2018 3:26:56 PM

Post# of 345681
Jerome Galon and Bernard Fox and gang....it is becoming very clear PS Targeting Biomarkers collected by Precision for Medicine and Epiontis etc via Sunrise have been benefiting those who have been collaborating with Peregrine (now Avid Bioservices ) so why is Roger Lias new CEO so arrogant and not realizing the value of PS Targeting?

If CEO Lias does not realize the impact of his failures to assess all of the assets ...including PS Targeting IP that are allowing an entirely new class of BIOMARKERS and new patents built upon PS Targeting ....verified with PS Targeting ...etc, then shareholders must take action to remove Lias and those that are not going to back PS Targeting

https://patents.justia.com/inventor/gabriela-bindea
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News